Cyclo Therapeutics Inc
NASDAQ:CYTH

Watchlist Manager
Cyclo Therapeutics Inc Logo
Cyclo Therapeutics Inc
NASDAQ:CYTH
Watchlist
Price: 0.72 USD -2.7% Market Closed
Market Cap: 20.7m USD
Have any thoughts about
Cyclo Therapeutics Inc?
Write Note

Cyclo Therapeutics Inc
Depreciation & Amortization

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Cyclo Therapeutics Inc
Depreciation & Amortization Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Depreciation & Amortization Analysis
Latest Figures & CAGR of Competitors

Company Depreciation & Amortization CAGR 3Y CAGR 5Y CAGR 10Y
Cyclo Therapeutics Inc
NASDAQ:CYTH
Depreciation & Amortization
-$14k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
22%
Abbvie Inc
NYSE:ABBV
Depreciation & Amortization
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Gilead Sciences Inc
NASDAQ:GILD
Depreciation & Amortization
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Depreciation & Amortization
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Depreciation & Amortization
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Depreciation & Amortization
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Cyclo Therapeutics Inc's Depreciation & Amortization?
Depreciation & Amortization
-14k USD

Based on the financial report for Jun 30, 2024, Cyclo Therapeutics Inc's Depreciation & Amortization amounts to -14k USD.

What is Cyclo Therapeutics Inc's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 10Y
22%

Over the last year, the Depreciation & Amortization growth was -40%.

Back to Top